Related Experiment Video
Updated: Apr 27, 2026

04:15
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
2.2K
A high throughput flow cytometric assay platform targeting transporter inhibition
George P Tegos1, Annette M Evangelisti2, J Jacob Strouse2
1Department of Dermatology, Harvard Medical School, Boston, MA 02114, United States.
Drug Discovery Today. Technologies
|July 17, 2014
Summary
High Throughput Screening (HTS) flow cytometry assays identify small molecules that inhibit transporter functions in mammalian and yeast systems. This technology advances strategies for targeting microbial efflux systems and understanding transporter biology.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Efflux pumps are crucial in drug resistance and cellular transport.
- High Throughput Screening (HTS) offers efficient methods for drug discovery.
- Flow cytometry provides a versatile platform for cellular analysis.
Purpose of the Study:
- To review the concepts, applications, and limitations of HTS flow cytometry-based efflux inhibitory assays.
- To highlight the potential of this platform in identifying novel transporter inhibitors.
- To explore its utility in targeting microbial efflux systems.
Main Methods:
- Utilizing flow cytometry for HTS of efflux inhibitory assays.
- Employing mammalian and yeast efflux systems for assay development.
- Analyzing data for identification of small molecules with transporter inhibitory capabilities.
Main Results:
- Successful application in mammalian and yeast efflux systems.
- Identification of small molecules with transporter inhibitory capabilities.
- Demonstration of substrate multiplexing potential.
Conclusions:
- HTS flow cytometry-based efflux assays are effective for identifying transporter inhibitors.
- This platform can facilitate novel strategies against microbial efflux systems.
- The generated datasets can map the chemistry-transporter biology interface in pathogenic systems.

